Corteva Catalyst
Venture arm of Corteva Agriscience; co-led $105m Tropic Biosciences Series B.
Corteva Catalyst, the venture arm of $17bn agrochemical group Corteva Agriscience, co-led Tropic Biosciences' $105m Series B on 1 March 2026, giving the Norwich gene-editing company its first major strategic backer.
Last refreshed: 31 July 2026 · Appears in 1 active topic
Is Corteva Catalyst positioning to acquire Tropic Biosciences?
Timeline for Corteva Catalyst
Mentioned in: Moa raises £22.2m to outrun resistance
UK Startups and InnovationMentioned in: Tropic Biosciences raises $105m from Norwich
UK Startups and InnovationBackground
Corteva Catalyst is the venture and innovation investment Arm of Corteva Agriscience, one of the world's largest agricultural chemicals and seeds companies, spun out of DowDuPont in 2019. Corteva Agriscience is headquartered in Indianapolis and has annual revenues of approximately $17bn, with operations spanning herbicides, fungicides, insecticides and proprietary seed genetics. Corteva Catalyst sits within this structure as the early-stage technology scouting and investing Arm, backing companies working on crop improvement, precision agriculture and biological crop protection.
Strategic investment from Corteva brings more than capital: it provides access to global regulatory expertise, field trial infrastructure and agricultural distribution channels across dozens of markets. Corteva Catalyst co-led the $105m Series B fundraise for Tropic Biosciences alongside Forbion and other investors, giving the Norwich-based gene-editing company backing from an industry strategic with the commercial distribution to help take crop traits to market at scale.
